Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.660,95
-0,10%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ CervoMed Inc (CRVO) CervoMed Inc (CRVO) Notizie

CRVO

CervoMed (CRVO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CRVO
DataOraFonteTitoloSimboloCompagnia
20/05/202414:00GlobeNewswire Inc.CervoMed to Appoint William Elder as Chief Financial OfficerNASDAQ:CRVOCervoMed Inc
15/05/202414:00GlobeNewswire Inc.CervoMed Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:CRVOCervoMed Inc
01/04/202414:00GlobeNewswire Inc.CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdatesNASDAQ:CRVOCervoMed Inc
28/03/202413:30GlobeNewswire Inc.CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare InvestorsNASDAQ:CRVOCervoMed Inc
05/03/202414:00GlobeNewswire Inc.CervoMed Announces Presentation of Biomarker Data from the AscenD-LB Phase 2a Trial and Preclinical Data Supporting Potential of Neflamapimod in Tau-Mediated Disease at AD/PD ™ 2024NASDAQ:CRVOCervoMed Inc
21/02/202414:00GlobeNewswire Inc.CervoMed to Participate in the BIO CEO and Investor ConferenceNASDAQ:CRVOCervoMed Inc
12/02/202414:00GlobeNewswire Inc.CervoMed Publishes Positive Results from AscenD-LB Phase 2a Trial in Peer-Reviewed Journal that Supports the Therapeutic Potential of Neflamapimod in Dementia with Lewy BodiesNASDAQ:CRVOCervoMed Inc
07/02/202414:30GlobeNewswire Inc.CervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the BoardNASDAQ:CRVOCervoMed Inc
05/02/202414:00GlobeNewswire Inc.CervoMed to Participate in the Emerging Growth Conference 67NASDAQ:CRVOCervoMed Inc
05/01/202414:00GlobeNewswire Inc.CervoMed to Participate in the Emerging Growth Conference 66NASDAQ:CRVOCervoMed Inc
13/11/202313:00PR Newswire (US)CervoMed Reports Third Quarter 2023 Financial Results and Business HighlightsNASDAQ:CRVOCervoMed Inc
25/10/202320:50PR Newswire (US)CervoMed Announces Oral Presentation at CTAD 2023 Highlighting Learnings from Phase 2a Which Optimized the Design of the Phase 2b Clinical Study of Neflamapimod in Dementia with Lewy BodiesNASDAQ:CRVOCervoMed Inc
24/10/202313:00PR Newswire (US)CervoMed Announces Publications in Major Peer-Reviewed Journals That Inform on Potential of Neflamapimod as a Disease-Modifying Therapy for the Major DementiasNASDAQ:CRVOCervoMed Inc
18/10/202313:00PR Newswire (US)CervoMed Announces Oral Presentation at CTAD 2023 Highlighting Phase 2b Neflamapimod Program for the Treatment of Patients with Dementia with Lewy BodiesNASDAQ:CRVOCervoMed Inc
05/10/202313:00PR Newswire (US)CervoMed to Present at the 2023 Roth Healthcare Opportunities ConferenceNASDAQ:CRVOCervoMed Inc
05/09/202313:00PR Newswire (US)CervoMed to Present at H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:CRVOCervoMed Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CRVO

La tua Cronologia

BIT
UCG
Unicredit
BIT
TIT
Telecom Italia
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
STMMI
ST Microelectronics
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TITR
Telecom Italia
BIT
ENEL
Enel
BIT
TEN
Tenaris
BIT
BPE
Bper Banca
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
PIRC
Pirelli & C
BIT
SPM
Saipem
BIT
MONC
Moncler
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network